Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

NCT00003816 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

361

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases
Nonmalignant Neoplasm
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: busulfan
DRUG: carboplatin
DRUG: cyclophosphamide
DRUG: etoposide
DRUG: fludarabine phosphate
DRUG: melphalan
DRUG: thiotepa
RADIATION: total-body irradiation

Sponsor

Roswell Park Cancer Institute